procyanidin has been researched along with Degenerative Disc Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HW; Guo, XD; Kang, JH; Kang, XW; Lin, AX; Liu, MQ; Liu, WZ; Wang, YD; Wang, ZH; Zhang, CY; Zhang, GZ | 1 |
| Hu, Y; Hu, Z; Huang, S; Liu, H; Shang, P; Tang, Q; Zhu, J | 1 |
2 other study(ies) available for procyanidin and Degenerative Disc Disease
| Article | Year |
|---|---|
Proanthocyanidins inhibit the apoptosis and aging of nucleus pulposus cells through the PI3K/Akt pathway delaying intervertebral disc degeneration.
Topics: Aging; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cells, Cultured; Humans; Intervertebral Disc; Intervertebral Disc Degeneration; Nucleus Pulposus; Phosphatidylinositol 3-Kinases; Proanthocyanidins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Quality of Life; Tumor Suppressor Protein p53 | 2022 |
Procyanidin B3 alleviates intervertebral disc degeneration via interaction with the TLR4/MD-2 complex.
Topics: Animals; Anti-Inflammatory Agents; Biflavonoids; Catechin; Cell Death; Cell Survival; Disease Models, Animal; Disease Progression; Extracellular Matrix; Humans; Intervertebral Disc Degeneration; Lipopolysaccharides; Lymphocyte Antigen 96; Male; Myeloid Differentiation Factor 88; NF-kappa B; Nucleus Pulposus; Proanthocyanidins; Punctures; Rats, Sprague-Dawley; Signal Transduction; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4 | 2020 |